RetractedArticleAnnals of translational medicine2020

Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients.

Jinzhang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.